Citadel Advisors’s Atossa Therapeutics ATOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,120
Closed -$18.8K 12960
2025
Q4
$18.8K Sell
2,120
-127
-6% -$1.61K ﹤0.01% 12354
2025
Q3
$29.2K Buy
2,247
+400
+22% +$4.94K ﹤0.01% 12406
2025
Q2
$23K Buy
1,847
+907
+96% +$10.8K ﹤0.01% 12071
2025
Q1
$9.49K Sell
940
-273
-23% -$3.31K ﹤0.01% 13597
2024
Q4
$17.2K Buy
1,213
+640
+112% +$12.5K ﹤0.01% 13268
2024
Q3
$13.1K Sell
573
-527
-48% -$10.6K ﹤0.01% 13078
2024
Q2
$19.6K Sell
1,100
-1,547
-58% -$34.2K ﹤0.01% 12657
2024
Q1
$71.5K Sell
2,647
-86
-3% -$1.38K ﹤0.01% 11793
2023
Q4
$36.1K Buy
2,733
+606
+28% +$6.54K ﹤0.01% 12104
2023
Q3
$23.5K Buy
2,127
+267
+14% +$3.87K ﹤0.01% 12495
2023
Q2
$35.2K Buy
1,860
+173
+10% +$2.1K ﹤0.01% 12192
2023
Q1
$18.3K Sell
1,687
-4,286
-72% -$47.8K ﹤0.01% 13129
2022
Q4
$47.4K Sell
5,973
-160
-3% -$1.84K ﹤0.01% 12206
2022
Q3
$77K Sell
6,133
-754
-11% -$10.9K ﹤0.01% 11304
2022
Q2
$113K Sell
6,887
-3,273
-32% -$51.6K ﹤0.01% 11294
2022
Q1
$191K Buy
10,160
+413
+4% +$8.39K ﹤0.01% 11592
2021
Q4
$234K Sell
9,747
-8,666
-47% -$317K ﹤0.01% 11514
2021
Q3
$900K Sell
18,413
-27,360
-60% -$1.59M ﹤0.01% 8424
2021
Q2
$4.34M Buy
45,773
+37,100
+428% +$1.96M ﹤0.01% 4743
2021
Q1
$275K Buy
8,673
+7,273
+520% +$266K ﹤0.01% 11040
2020
Q4
$20K Buy
1,400
+487
+53% +$11.3K ﹤0.01% 10778
2020
Q3
$33K Buy
913
+233
+34% +$11.2K ﹤0.01% 9732
2020
Q2
$39K Buy
+680
New +$24.1K ﹤0.01% 9397

Other funds holding ATOS